NaCl is one of 564 small molecule programs targeting Fatigue. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
NaCl
Prolia
Adenocard
Blenoxane
MS Contin
Zinecard
Acupan
Paracetamol
QS21
Diuretic
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources